|
gptkbp:instanceOf
|
controlled substance
opioid
narcotic
|
|
gptkbp:administeredBy
|
intramuscular injection
subcutaneous injection
intravenous injection
|
|
gptkbp:alsoKnownAs
|
amphetamine
|
|
gptkbp:ATCCode
|
N02AA06
|
|
gptkbp:CASNumber
|
561-27-3
|
|
gptkbp:chemicalFormula
|
C21H23NO5
|
|
gptkbp:discoveredBy
|
gptkb:C._R._Alder_Wright
|
|
gptkbp:discoveredIn
|
1874
|
|
gptkbp:eliminationHalfLife
|
2–3 minutes (diamorphine), 2–3 hours (morphine)
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:hasInChIKey
|
gptkb:GVGLGOZIDCSQPN-UHFFFAOYSA-N
|
|
gptkbp:hasSMILES
|
CC(=O)Oc1ccc2C[C@H]3N(CCc4c3ccc(OC(C)=O)c4O2)c5ccc(O)c1c5
|
|
gptkbp:hasWikipediaPage
|
https://en.wikipedia.org/wiki/Heroin
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
diamorphine
|
|
gptkbp:IUPACName
|
(5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diyl diacetate
|
|
gptkbp:KEGGID
|
D07801
|
|
gptkbp:legalStatus
|
gptkb:Schedule_I_(US)
gptkb:Class_A_(UK)
|
|
gptkbp:marketedAs
|
gptkb:Bayer
|
|
gptkbp:MeSH_ID
|
D006526
|
|
gptkbp:metabolism
|
gptkb:morphine
|
|
gptkbp:molecularWeight
|
369.4 g/mol
|
|
gptkbp:pregnancyCategory
|
UK: C
|
|
gptkbp:prodrugOf
|
gptkb:morphine
|
|
gptkbp:PubChem_CID
|
gptkb:DB01452
4575371
5462328
CHEBI:27941
|
|
gptkbp:routeOfAdministration
|
injection
intranasal
oral (rarely)
|
|
gptkbp:sideEffect
|
addiction
nausea
constipation
respiratory depression
|
|
gptkbp:UNII
|
76Q6JBO79Y
|
|
gptkbp:usedFor
|
pain management
palliative care
|
|
gptkbp:bfsParent
|
gptkb:D006_Heroin
|
|
gptkbp:bfsLayer
|
7
|